XML 68 R51.htm IDEA: XBRL DOCUMENT
v3.19.1

Financial Instruments and Financial Risk Management (Details 1) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016
Statement Line Items [Line Items] |  |  |  |  |
Classification to equity of Series B warrants |  |  | $ 2,286 |  |
Exercise of anti-dilution feature |  | $ 2,302 |  |  |
Level 3 Instruments [Member] |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |
Balance |  | 753 | 94 |  | [1]
Initial recognition |  | 753 | 2,273 | 299 |
Finance expenses (income) |  | 3,175 | (1,614) | 1,044 |
Classification to equity of Series B warrants |  | 2,239 |  | (1,249) |
Classification to level 1 (see Note 13(e)) |  | (3,479) |  | 94 |
Exercise of anti-dilution feature |  | (901) |  | (12) |
Settlement/cancellation |  | (1,787) |  |  |
Balance |  |  | 753 | 94 |
Total unrealized losses for the period included in profit or loss for liabilities held |  | 2,239 | (1,614) | (12) |
Level 3 Instruments [Member] | Bridge Loan [Member] |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |
Balance |  |  |  |  | [1]
Initial recognition |  |  |  |  |
Finance expenses (income) | [2] |  |  | 800 |
Classification to equity of Series B warrants |  |  |  | (800) |
Classification to level 1 (see Note 13(e)) |  |  |  |  |
Exercise of anti-dilution feature |  |  |  |  |
Balance |  |  |  |  |
Total unrealized losses for the period included in profit or loss for liabilities held |  |  |  |  |
Level 3 Instruments [Member] | Financing of Issuance Expenses [Member] |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |
Balance |  |  |  |  | [1]
Initial recognition |  |  |  |  |
Finance expenses (income) | [2] |  |  | 256 |
Classification to equity of Series B warrants |  |  |  | (256) |
Classification to level 1 (see Note 13(e)) |  |  |  |  |
Exercise of anti-dilution feature |  |  |  |  |
Balance |  |  |  |  |
Total unrealized losses for the period included in profit or loss for liabilities held |  |  |  |  |
Level 3 Instruments [Member] | Derivative Financial Instruments [Member] |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |
Balance |  | 61 |  |  |
Initial recognition |  | 61 | 1,958 |  |
Finance expenses (income) |  | 2,678 | (1,897) |  |
Classification to equity of Series B warrants |  | 1,641 |  |  |
Classification to level 1 (see Note 13(e)) |  | (3,479) |  |  |
Exercise of anti-dilution feature |  | (901) |  |  |
Settlement/cancellation |  |  |  |  |
Balance |  |  | 61 |  |
Total unrealized losses for the period included in profit or loss for liabilities held |  | 1,641 | (1,897) |  |
Level 3 Instruments [Member] | Options to Group Of Investors [Member] |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |
Balance |  |  |  |  |
Initial recognition |  |  |  | 193 |
Finance expenses (income) |  |  |  |  |
Classification to equity of Series B warrants |  |  |  | (193) |
Classification to level 1 (see Note 13(e)) |  |  |  |  |
Exercise of anti-dilution feature |  |  |  |  |
Balance |  |  |  |  |
Total unrealized losses for the period included in profit or loss for liabilities held |  |  |  |  |
Anti-Dilution Feature [Member] | Level 3 Instruments [Member] |  |  |  |  |
Statement Line Items [Line Items] |  |  |  |  |
Balance |  | 692 | 94 |  |
Initial recognition |  | 692 | 315 | 106 |
Finance expenses (income) |  | 497 | 283 | (12) |
Classification to equity of Series B warrants |  | 598 |  |  |
Classification to level 1 (see Note 13(e)) |  |  |  | 94 |
Exercise of anti-dilution feature |  |  |  | (12) |
Settlement/cancellation |  | (1,787) |  |  |
Balance |  |  | 692 | 94 |
Total unrealized losses for the period included in profit or loss for liabilities held |  | $ 598 | $ 283 | $ (12) |
[1] | Represents an amount of less than $ 1 thousands.
[2] | Recognition of deferred initial loss at an amount equal to the cash amount paid by the Company at the time of completion the Merger Transaction.

X
- Definition Classification of fair value. + References No definition available. + Details
Name: | SFET_ClassificationOfFairValue
Namespace Prefix: | SFET_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The exercise of anti-dilution feature. + References No definition available. + Details
Name: | SFET_ExerciseOfAntidilutionFeature
Namespace Prefix: | SFET_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Fair value settlement or cancellation + References No definition available. + Details
Name: | SFET_FairValueSettlementCancellation
Namespace Prefix: | SFET_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | SFET_IfrsStatementLineItems
Namespace Prefix: | SFET_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Initial recognition of fair value. + References No definition available. + Details
Name: | SFET_InitialRecognitionFairValueEstimation
Namespace Prefix: | SFET_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Unrealized losses for the period included in profit or loss for liabilities. + References No definition available. + Details
Name: | SFET_UnrealizedLossesForPeriodIncludedInProfitOrLoss
Namespace Prefix: | SFET_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of financial liabilities that meet either of the following conditions: (a) they meet the definition of held for trading; or (b) upon initial recognition they are designated by the entity as at fair value through profit or loss. An entity may use this designation only when permitted by paragraph 4.3.5 of IFRS 9 (embedded derivatives) or when doing so results in more relevant information, because either: (a) it eliminates or significantly reduces a measurement or recognition inconsistency (sometimes referred to as ‘an accounting mismatch’) that would otherwise arise from measuring assets or liabilities or recognising the gains and losses on them on different bases; or (b) a group of financial liabilities or financial assets and financial liabilities is managed and its performance is evaluated on a fair value basis, in accordance with a documented risk management or investment strategy, and information about the group is provided internally on that basis to the entity’s key management personnel (as defined in IAS 24). [Refer: At fair value [member]; Key management personnel of entity or parent [member]; Derivatives [member]; Financial assets; Financial liabilities] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2018-01-01 -Paragraph 8 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=7&date=2018-03-01&anchor=para_8_e&doctype=Standard -URIDate 2018-03-16 + Details
Name: | ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The increase (decrease) in equity resulting from the exercise of warrants. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2018-01-01 -Paragraph 106 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2018-03-01&anchor=para_106_d&doctype=Standard -URIDate 2018-03-16 + Details
Name: | ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2018-01-01 -Paragraph 85 -URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=1&date=2018-03-01&anchor=para_85&doctype=Standard -URIDate 2018-03-16 + Details
Name: | ifrs-full_OtherFinanceIncomeCost
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | SFET_FinancingActivitiesAxis=SFET_BridgeLoansMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | SFET_FinancingActivitiesAxis=SFET_FinancingExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | SFET_FairValueLiabilitiesAxis=SFET_DerivativeFinancialMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | SFET_FairValueLiabilitiesAxis=SFET_OptionsInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | SFET_ValuationAllowancesAxis=SFET_AntiDilutionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |